Paces Ferry Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$268K Buy
4,423
+151
+4% +$8.8K 0.11% 111
2025
Q4
$230K Buy
+4,272
New +$206K 0.09% 117
2025
Q3
Sell
-4,515
Closed -$209K 129
2025
Q2
$209K Sell
4,515
-296
-6% -$14.5K 0.1% 116
2025
Q1
$293K Sell
4,811
-32
-0.7% -$1.86K 0.15% 91
2024
Q4
$274K Buy
+4,843
New +$271K 0.13% 100
2020
Q4
Sell
-1,061
Closed -$64K 243
2020
Q3
$64K Buy
+1,061
New +$63.9K 0.06% 206

Other funds holding BMY

Paces Ferry Wealth Advisors's BMY Position: Q1 2026 in Review

Paces Ferry Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q1 2026, buying an estimated $8.8K and bringing the position to 4,423 shares worth $268K. The position accounts for 0.11% of the portfolio, ranked #111.

Paces Ferry Wealth Advisors first reported a position in BMY in Q3 2020 and has held it in 6 quarters since. The position peaked at $293K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Paces Ferry Wealth Advisors held 4,423 shares of Bristol-Myers Squibb worth $268K as of Q1 2026.
  • Paces Ferry Wealth Advisors bought 151 Bristol-Myers Squibb shares in Q1 2026, an estimated $8.8K.
  • Bristol-Myers Squibb made up 0.11% of Paces Ferry Wealth Advisors's portfolio in Q1 2026, its #111 holding.
  • Paces Ferry Wealth Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 6 quarters since.
  • Paces Ferry Wealth Advisors's Bristol-Myers Squibb position peaked at $293K in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Paces Ferry Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.